Francesco Bellini

Dr. Francesco Bellini is a Chairman at FB Vision SRL, a Chairman & Chief Executive Officer at KLOX Technologies, Inc., a Chairman at BELLUS Health, Inc., a Chairman at Picchio International, Inc., a Chairman at Domodimonti SRL SA, a Chairman at Prognomix, Inc., a Chairman & President at Neurochem (International) Ltd. and a Director & Executive Vice President at Picchio Pharma, Inc. He is on the Board of Directors at Montreal Heart Institute Foundation, Bellus Health (Innodia), Inc., Iniziative Immobiliari Marchigiane SRL, Italian Chamber of Commerce of Ontario and Picchio Pharma, Inc. Dr. Bellini was previously employed as a Founder by FB Vision SpA, a Chairman by Pharma Research /IT/, an Independent Director by Molson Coors Brewing Co., a Chairman by ViroChem Pharma, Inc., a Chairman & Chief Executive Officer by Biochem Pharma, Inc., a Chairman by Adaltis, Inc., a Chairman by Ascoli Picchio F.C.
1898 SpA, and a Chairman by Neuraxpharm Italy SpA. He also served on the board at Stem Cell Therapeutics Corp., Molson Coors Canada, Inc., Molson ULC, Canada Foundation for Sustainable Development Technology and Science, Technology & Innovation Council.
He received his undergraduate degree from Concordia University and a doctorate degree from the University of New Brunswick.